| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2007 | US20070043087 Compounds exhibiting thrombopoietin receptor agonism |
| 02/22/2007 | US20070043085 Process for the preparation of amorphous form of neutral esomeprazole |
| 02/22/2007 | US20070043084 1,2-Diarylimidazoles useful as inhibitors of cox |
| 02/22/2007 | US20070043083 Thiazolyl piperidine derivatives |
| 02/22/2007 | US20070043082 Use of antimuscarinic drugs |
| 02/22/2007 | US20070043081 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043078 Angiogenesis inhibitor |
| 02/22/2007 | US20070043077 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 02/22/2007 | US20070043076 Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis |
| 02/22/2007 | US20070043075 2-Methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
| 02/22/2007 | US20070043074 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 02/22/2007 | US20070043073 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/22/2007 | US20070043072 Cancers that express nitric oxide synthase; 2-[2-(2-Amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine |
| 02/22/2007 | US20070043071 Further therapeutic use of zolpidem |
| 02/22/2007 | US20070043070 Weak base salts |
| 02/22/2007 | US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans |
| 02/22/2007 | US20070043068 Pyrrolo-pyridine kinase modulators |
| 02/22/2007 | US20070043067 7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/22/2007 | US20070043066 N1-benzyl-N2-[(4'-ethynyl-1,1'-biphenyl-4-yl)carbonyl]-L- alpha -glutamine; protease inhibitors; metalloenzyme inhibitors; anticarcinogenic agents; asthma; chronic obstructive pulmonary disease; atherocslerosis; aound healing agents; angiogenesis inhibitors; liver disorders; vision defects; shock |
| 02/22/2007 | US20070043065 Amide derivatives |
| 02/22/2007 | US20070043064 7-Substituted 3-nitro-pyrazo[1,5-a] pyrimidines |
| 02/22/2007 | US20070043063 Such as 3-(2-Methanesulfonyl-pyrimidin-4-yl)-5-pyridin-3-yl-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine; heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, destructive bone disorders |
| 02/22/2007 | US20070043062 Isoxazoles as peptide deformylase inhibitors |
| 02/22/2007 | US20070043061 Furazanobenzimidazoles |
| 02/22/2007 | US20070043060 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine |
| 02/22/2007 | US20070043059 N-oxides as prodrugs of piperazine and piperidine derivatives |
| 02/22/2007 | US20070043058 Novel 2,3-dihydroindole compounds |
| 02/22/2007 | US20070043057 Lonidamine analogs |
| 02/22/2007 | US20070043056 5-Substituted-2-arylpyrazines |
| 02/22/2007 | US20070043055 Dihydropteridinones in the treatment of respiratory diseases |
| 02/22/2007 | US20070043054 Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043052 Reverse-turn mimetics and method relating thereto |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043050 Sirtuin modulating compounds |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043046 Biaromatic ligand activators of PPARGAMMA receptors |
| 02/22/2007 | US20070043045 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | US20070043044 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070043035 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 02/22/2007 | US20070043034 Chlorine Ion Uptake Modulators and Uses Thereof |
| 02/22/2007 | US20070043033 Unsolvated benzodiazepine compositions and methods |
| 02/22/2007 | US20070043032 Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist |
| 02/22/2007 | US20070043031 Non-amide nonanes |
| 02/22/2007 | US20070043030 Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation |
| 02/22/2007 | US20070043029 11-Phenyl-dibenzodiazepine derivatives as rxr-antagonists |
| 02/22/2007 | US20070043028 Compositions of novel opioid compounds and method of use thereof |
| 02/22/2007 | US20070043027 Sulfonamide derivatives for the treatment of diabetes |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | US20070043025 Administering epinastine or a salt such as the hydrochloride; reduces contact lens intolerance. |
| 02/22/2007 | US20070043024 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 02/22/2007 | US20070043023 Modulators of muscarinic receptors |
| 02/22/2007 | US20070043022 2-[6-{[2-(3-Hydroxy-propyl)-5-methyl-phenylamino]-methyl}-2-(3-morpholin-4-yl-propylamino)-benzimidazol-1-ylmethyl]-6-methyl-pyridin-3-ol, or its N-oxide, salt, quaternary amine, or metal complex; optionally with an additional antiviral agent |
| 02/22/2007 | US20070043021 Olanzapine analogs and methods of use thereof |
| 02/22/2007 | US20070043020 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 02/22/2007 | US20070043019 Salt and crystalline forms thereof of a drug |
| 02/22/2007 | US20070043018 2"-Hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 02/22/2007 | US20070043017 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/22/2007 | US20070043016 Method of treating fibrotic diseases or other indications with imidazolium agents |
| 02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 02/22/2007 | US20070043014 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/22/2007 | US20070043013 1,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 02/22/2007 | US20070043012 Methods to enhance chemotherapy |
| 02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
| 02/22/2007 | US20070043010 Quinazoline derivatives |
| 02/22/2007 | US20070043009 Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/22/2007 | US20070043008 Condensed Bicyclo[3.1.0] Hex-4-EN Derivatives Useful as Antibacterial Agents |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/22/2007 | US20070043006 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070043004 High drug load mesalazine sachet |
| 02/22/2007 | US20070043003 Novel compounds for the prophylaxis and treatment of inflammatory bowel diseases |
| 02/22/2007 | US20070043002 Aldolase-inhibiting aromatic compounds |
| 02/22/2007 | US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties |
| 02/22/2007 | US20070043000 Immunosuppresive effects of pteridine derivatives |
| 02/22/2007 | US20070042999 Phosphate derivatives of pharmaceutical products |
| 02/22/2007 | US20070042998 Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein |
| 02/22/2007 | US20070042997 Medicament for treatment of dermal pigmentation |
| 02/22/2007 | US20070042995 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria |
| 02/22/2007 | US20070042994 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 02/22/2007 | US20070042993 preparation of sulphated glycosaminoglycans derived from N acetylheparosan comprising N-deacetylation and N-sulphation of N-acetylheparosan polysaccharide prepared from natural or recombinant bacterial strain, preferably K5 E. coli, enzymatic epimerization with glucuronyl C5-epimerase enzyme, sulfation |
| 02/22/2007 | US20070042992 Inulin products with improved nutritional properties |
| 02/22/2007 | US20070042991 Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042989 Novel 2'-C-methyl nucleoside derivatives |
| 02/22/2007 | US20070042988 (S)-2-{[(2R,3S,4R,5R)-5-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-3-phenyl-propionic acid ethyl ester, for example; treatment of Hepatitis C Virus (HCV) mediated diseases |
| 02/22/2007 | US20070042987 Stereoselective synthesis of beta-nucleosides |
| 02/22/2007 | US20070042979 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 02/22/2007 | US20070042976 Method of treating cosmetic and dermatologic conditions by a demethylating agent |